Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03049293Phase 1Terminated
Phase 1 trial of midazolam in infertility (2 arms), sponsored by ART Fertility Clinics. Primary endpoint: Midazolam values measured by the time from the injection of Midazolam to the oocyte aspiration. Started Jun 2017; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03049293.